Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
about
Update on the pathogenesis of Scleroderma: focus on circulating progenitor cellsCXCR3 in carcinoma progressionChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsChemokines as effector and target molecules in vascular biologyAlternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasisPF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier BreakdownThe Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerizationCXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancerRole of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Macrophages and chemokines as mediators of angiogenesis.Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitroEpithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.Regulation of leukocyte function by adenosine receptors.CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection.Differential regulation of pericyte function by the CXC receptor 3.Platelet-macrophage partnership in innate immunity and inflammation.CXCL4 is a novel nickel-binding protein and augments nickel allergy.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
P2860
Q26751234-34610B25-20BA-42BE-8021-BA16A5FACCFAQ26826928-1A28E415-FC99-4817-BA3B-65FF49619933Q26830743-E7AC3F81-AA53-4C29-B524-862BE1D7740DQ27024341-EC08AF64-B9DA-4CF7-93D2-BD6708816E3FQ27677101-EE0C6D4B-76AB-4F2C-B263-64C7CDC0790DQ33709419-5A5A61C7-5C8D-40B7-9634-58563AE92D80Q34181664-92369706-248B-4044-B5C3-78702FB2D2A0Q34391833-465C8C87-CC14-46EF-8728-A82CDB4C8050Q34786603-2443F6FE-F740-4609-BB7A-88E116FF56F2Q35195333-133397D4-311C-4B33-B033-CE86A1979250Q36065054-C157C97B-A261-4EDB-93D7-8C1CCA8B20FAQ36530735-17D64F1C-E14F-4A73-8CFC-8E3C838D7929Q36685419-29CB48AF-7F17-4E9F-B5A8-9352902F35F4Q36698872-C4316400-6CD4-4199-992F-84FAF926BD6BQ36960001-F91A1A93-6F34-4AA1-88BB-A2FD3810CD4EQ36983319-1F1428CA-26C5-4BA1-A992-1901402CE0E5Q37226482-9C94A793-5547-4477-B142-7D8A620A7B1FQ37474379-8326BDBE-134C-43AA-9179-441492409E81Q37876538-3329DD37-C893-4D34-9193-392B7F81206AQ39029960-05B60CA5-D0AB-4F86-AC43-C2EDD70A5FF8Q40359006-DE153A30-BDA5-4B42-BE40-6F50946BCD7BQ40700201-B20DBB6A-FB9F-43E7-9848-8FAADAB3DCDCQ47980827-61EC8E93-1687-4F6D-A459-436CE9B43887Q48102885-BD9AC769-8E5A-4361-A6E5-0859BB20368BQ49524220-6077B19B-157E-45B2-8FBC-EEE8C0D8E300Q50801488-5F2074C8-67FC-4397-9E50-6293A4DC038CQ55365331-52F5B468-AA23-4FD6-907B-4F2448CDEDBEQ58758969-BBE52489-87E0-4BE9-A387-03B3AE578382
P2860
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@ast
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@en
type
label
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@ast
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@en
prefLabel
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@ast
Angiostatic and chemotactic ac ...... ariant) are mediated by CXCR3.
@en
P2093
P2860
P50
P1433
P1476
Angiostatic and chemotactic ac ...... variant) are mediated by CXCR3
@en
P2093
Craig Gerard
Jo Vandercappellen
Laura Salogni
Marie D Burdick
Mieke Gouwy
Robert M Strieter
P2860
P304
P356
10.1182/BLOOD-2009-11-253591
P407
P577
2010-10-27T00:00:00Z